Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.

Pondo T, Rose CE Jr, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM.

Vaccine. 2014 Jun 12;32(28):3548-54. doi: 10.1016/j.vaccine.2014.04.025. Epub 2014 Apr 24.

PMID:
24768633
2.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
3.
4.

Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial.

Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM.

Vaccine. 2012 Aug 31;30(40):5875-9. doi: 10.1016/j.vaccine.2012.06.076. Epub 2012 Jul 17.

PMID:
22814409
5.

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB.

J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16.

6.

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.

Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, Kotloff KL, Rouphael N, Noah DL, Hill H, Wolff MC.

J Infect Dis. 2012 Sep 15;206(6):811-20. doi: 10.1093/infdis/jis427. Epub 2012 Jul 10.

7.

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.

Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, Wald A, Poland G, Jacobson R, Keyserling HL, Spearman P, Hill H, Wolff M; National Institute of Allergy and Infectious Diseases-Funded Vaccine and Treatment Evaluation Units.

J Infect Dis. 2011 Mar 1;203(5):666-73. doi: 10.1093/infdis/jiq093. Epub 2011 Jan 31.

8.

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ.

BMC Infect Dis. 2010 Mar 17;10:71. doi: 10.1186/1471-2334-10-71.

9.

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, Ahmed R.

J Immunol. 2009 Dec 15;183(12):7919-30. doi: 10.4049/jimmunol.0803903. Epub .

10.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
11.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group.

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

12.

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

Shuler CM, Iwamoto M, Bridges CB, Marin M, Neeman R, Gargiullo P, Yoder TA, Keyserling HL, Terebuh PD.

Pediatrics. 2007 Mar;119(3):e587-95.

13.

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea.

Wang Y, Dennehy PH, Keyserling HL, Tang K, Gentsch JR, Glass RI, Jiang B.

J Virol. 2007 Apr;81(8):3904-12. Epub 2007 Jan 31.

14.

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.

Keyserling HL, Pollard AJ, DeTora LM, Gilmet GP.

Expert Rev Vaccines. 2006 Aug;5(4):445-59. Review.

PMID:
16989625
15.

Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.

Kapogiannis BG, Satola S, Keyserling HL, Farley MM.

Clin Infect Dis. 2005 Dec 1;41(11):e97-103. Epub 2005 Oct 25.

16.

Vancomycin use in hospitalized pediatric patients.

Keyserling HL, Sinkowitz-Cochran RL, Harris JM 2nd, Levine GL, Siegel JD, Stover BH, Lau SA, Jarvis WR; Pediatric Prevention Network.

Pediatrics. 2003 Aug;112(2):e104-11.

PMID:
12897315
17.

Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response.

Kim MJ, Nafziger AN, Harro CD, Keyserling HL, Ramsey KM, Drusano GL, Bertino JS Jr.

Vaccine. 2003 Mar 7;21(11-12):1174-9.

PMID:
12559795
18.

Progress report--Georgia Immunization Registry.

Keyserling HL.

J Med Assoc Ga. 2002 Summer;91(2):31. No abstract available.

PMID:
12189962
19.

Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples.

Helfand RF, Keyserling HL, Williams I, Murray A, Mei J, Moscatiello C, Icenogle J, Bellini WJ.

J Med Virol. 2001 Dec;65(4):751-7.

PMID:
11745941
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk